tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab Advances Rina-S Into Phase 3 Ovarian Cancer Trial, Setting Up a New Long-Term Catalyst
Company AnnouncementsGenmab Advances Rina-S Into Phase 3 Ovarian Cancer Trial, Setting Up a New Long-Term Catalyst
15h ago
GMAB
Genmab Expands Rina-S Ovarian Cancer Program in China, Raising Long-Term Upside Potential
PremiumCompany Announcements
Genmab Expands Rina-S Ovarian Cancer Program in China, Raising Long-Term Upside Potential
2d ago
GMAB
Genmab Reports Board Member Share Sale Under EU Market Abuse Rules
PremiumCompany Announcements
Genmab Reports Board Member Share Sale Under EU Market Abuse Rules
5d ago
6K
GMAB
Genmab assumed with a Buy at Truist
PremiumThe Fly
Genmab assumed with a Buy at Truist
8d ago
GMAB
PremiumRatings
Charlie Haywood Reiterates Buy on Genmab, Keeps DKK 2,500 Price Target on Strength of Late-Stage Pipeline and Favorable Risk-Reward
14d ago
GMAB
Genmab (OTC) Maps Catalyst-Rich Path After Strong Q1
PremiumCompany AnnouncementsGenmab (OTC) Maps Catalyst-Rich Path After Strong Q1
15d ago
GMAB
Analyst Maintains Buy on Genmab as Expanded Petosemtamab Phase III Program Strengthens Late-Stage HNSCC Outlook
Premium
Ratings
Analyst Maintains Buy on Genmab as Expanded Petosemtamab Phase III Program Strengthens Late-Stage HNSCC Outlook
16d ago
GMAB
Premium
Ratings
Genmab: Buy Rating Reiterated on Strong Clinical Catalysts, Unchanged DKK 2,500 Price Target
20d ago
GMAB
Genmab Earnings Call: Strong Growth, Big Pipeline Bets
PremiumCompany Announcements
Genmab Earnings Call: Strong Growth, Big Pipeline Bets
20d ago
GMAB
Genmab Updates Articles of Association, Expands Capital and Incentive Authorizations
PremiumCompany Announcements
Genmab Updates Articles of Association, Expands Capital and Incentive Authorizations
22d ago
6K
GMAB
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
PremiumCompany Announcements
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
23d ago
6K
GMAB
Genmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche Bank
PremiumThe Fly
Genmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche Bank
24d ago
GMAB
Genmab announces 5.08% stake by Orbis Investment
PremiumThe FlyGenmab announces 5.08% stake by Orbis Investment
26d ago
GMAB
Genmab Discloses Orbis as 5.08% Major Shareholder
Premium
Company Announcements
Genmab Discloses Orbis as 5.08% Major Shareholder
26d ago
6K
GMAB
Yaron Werber Reiterates Hold on Genmab, Citing Strong Execution but 2026‑Weighted Catalyst Risk Profile
Premium
Ratings
Yaron Werber Reiterates Hold on Genmab, Citing Strong Execution but 2026‑Weighted Catalyst Risk Profile
27d ago
GMAB
Genmab Terminates Early-Stage GEN1057 Cancer Trial: What Investors Should Watch Next
PremiumCompany Announcements
Genmab Terminates Early-Stage GEN1057 Cancer Trial: What Investors Should Watch Next
27d ago
GMAB
Genmab Halts Early-Stage GEN1286 Cancer Trial: What Investors Should Know
PremiumCompany Announcements
Genmab Halts Early-Stage GEN1286 Cancer Trial: What Investors Should Know
27d ago
GMAB
Genmab price target lowered to $33 from $34 at Morgan Stanley
PremiumThe Fly
Genmab price target lowered to $33 from $34 at Morgan Stanley
27d ago
GMAB
Genmab: Buy Rating Reiterated as 2026 Pivotal Data Catalysts and Strong Epkinly Momentum Make 15% Share Pullback an Attractive Entry Point
PremiumRatings
Genmab: Buy Rating Reiterated as 2026 Pivotal Data Catalysts and Strong Epkinly Momentum Make 15% Share Pullback an Attractive Entry Point
27d ago
GMAB
Genmab reports Q1 operating profit $180M, consensus $172.7M
PremiumThe FlyGenmab reports Q1 operating profit $180M, consensus $172.7M
28d ago
GMAB
Genmab maintains FY26 guidance
Premium
The Fly
Genmab maintains FY26 guidance
28d ago
GMAB
Genmab Advances Rina S Into Phase 2 GI Cancer Trial, Raising Long Term Pipeline Hopes
Premium
Company Announcements
Genmab Advances Rina S Into Phase 2 GI Cancer Trial, Raising Long Term Pipeline Hopes
28d ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >